• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS SMARTSITE GRAVITY BLOOD SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS SMARTSITE GRAVITY BLOOD SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 10010903
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/31/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B3.The date received by manufacturer has been used for this field.H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd alaris smartsite gravity blood set separated the following information was received by the initial reporter with the following verbatim: rcc received a complaint via email.Email(s) attached.The bag spikes are separating from the tubing.
 
Additional Manufacturer Narrative
It was reported that the tubing separated from the bag spikes.One sample model 10010903, lot 24029351 was returned for investigation.The set was examined for defects and abnormalities.The tubings were separated from the bag spikes.No other defects or abnormalities were observed.Visual inspection under the microscope showed no signs of solvent on the tubing.The customer complaint was verified and a quality notification was sent to the manufacturer.A device history record review for model 10010903 lot number 24029351 was performed.The search showed that a total of (b)(4) units in 1 lot number was built on 15feb2024.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.From the manufacturer's investigation, the potential root cause is due to the assembler using an incorrect solvent application method.A quality alert was created on june 10th, 2024 to communicate the failure and reinforce the correct solvent application method and correct use of the fixture to avoid the separation due to lack of solvent.
 
Event or Problem Description
No additional info.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS SMARTSITE GRAVITY BLOOD SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key19608275
Report Number9616066-2024-00927
Device Sequence Number6334486
Product Code FPA
UDI-Device Identifier07613203020879
UDI-Public(01)07613203020879
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K050115
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number10010903
Device Lot Number24029351
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/31/2024
Supplement Date Received by Manufacturer08/12/2024
Initial Report FDA Received Date06/25/2024
Supplement Report FDA Received Date08/21/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/15/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-